Antibody staining confirmed that the samples displayed a wide range of immune infiltrate levels (CD45+ cells), endothelial cells (CD31+) and cancer cell markers (CA IX, CD10, and EpCam), indicating variability in tumor cell profiles within the collected samples (Figure 1C). This evidence concerns the gene CA9 and cancer.